Avian Influenza Virus Tropism in Humans

Viruses. 2023 Mar 24;15(4):833. doi: 10.3390/v15040833.

Abstract

An influenza pandemic happens when a novel influenza A virus is able to infect and transmit efficiently to a new, distinct host species. Although the exact timing of pandemics is uncertain, it is known that both viral and host factors play a role in their emergence. Species-specific interactions between the virus and the host cell determine the virus tropism, including binding and entering cells, replicating the viral RNA genome within the host cell nucleus, assembling, maturing and releasing the virus to neighboring cells, tissues or organs before transmitting it between individuals. The influenza A virus has a vast and antigenically varied reservoir. In wild aquatic birds, the infection is typically asymptomatic. Avian influenza virus (AIV) can cross into new species, and occasionally it can acquire the ability to transmit from human to human. A pandemic might occur if a new influenza virus acquires enough adaptive mutations to maintain transmission between people. This review highlights the key determinants AIV must achieve to initiate a human pandemic and describes how AIV mutates to establish tropism and stable human adaptation. Understanding the tropism of AIV may be crucial in preventing virus transmission in humans and may help the design of vaccines, antivirals and therapeutic agents against the virus.

Keywords: antiviral; avian influenza virus; influenza A virus; vaccine; virus tropism in humans.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Birds
  • Humans
  • Influenza A virus* / genetics
  • Influenza A virus* / metabolism
  • Influenza in Birds*
  • Influenza, Human*
  • Tropism

Grants and funding

This research was financially supported by the Ministry of Higher Education Malaysia for niche area research under the Higher Institution Centre of Excellence (HICoE) program (Project MO002-2019) and by the Ministry of Education Malaysia Fundamental Research Grant Scheme (FRGS/1/2022/STG03/UM/02/6).